View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Excellence Awards 2022

Rankings: Business Expansion

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector.

Excellence Rankings 2022

The Excellence Rankings celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change.

Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.

FEATURED COMPANIES
COMMENDED:
• Innovation
• Product Launch
• Safety
VIEW PROFILEIllinois based producer of medical devices and technologies
COMMENDED:
• Business Expansion
• Innovation
• Investments
VIEW PROFILEA business and technology consultancy firm focused on life sciences

Is your company ranked?

If you want to learn more about the Rankings and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:

Contact: Sundeep Makkar – Sundeep.Makkar@Verdict.co.uk

Free White Paper

Pharmaceutical Technology Excellence Awards & Rankings 2022 – Media Pack

By Excellence Awards
Enter your details to receive the free paper:

What is Business Expansion?

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector.

This consists of any projects that have expanded the company’s footprint in the sector, including: contract wins; launching in new territories; launching new product lines; the acquisition and expansion of facilities and real estate; acquisition of new machinery or other assets; improved logistics; partnerships; and significant staff increases.

Ranking Categories

This category highlights companies that have expanded their portfolios through acquisitions of new lines, brands or businesses.


This category highlights newly established companies, whether they be start-ups or new portfolio companies of existing market entities.


This category highlights those companies that have added new product lines to their portfolios, whether that be expansion in existing markets or entry into new ones or development of new materials. The category also includes companies that have widened their distribution.


This category highlights companies that have expanded their research and development efforts in the area of central nervous system medicine through investments and partnerships.


This category highlights companies that have expanded their research and development efforts in the areas of genetic disease and gene therapy through investments and partnerships.


This category highlights companies that have expanded their research and development efforts in the area of immunology through investments and partnerships.


This category highlights companies that have expanded their research and development efforts in the area of infectious disease through investments and partnerships.


This category highlights companies that have expanded their research and development efforts in the area of metabolic medicine through investments and partnerships.


This category highlights companies that have expanded their research and development efforts in the area of oncology through investments and partnerships.


This category highlights companies that have expanded their research and development efforts in the area of respiratory medicine through investments and partnerships.


This category highlights companies that have expanded their manufacturing or research and development capability through investment in new facilities or the expansion of existing ones.


This category highlights companies that have expanded their research and development efforts in the area of vaccines through investments and partnerships.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology